Trial Profile
A PHASE I/II (PILOT) RANDOMIZED SINGLE BLIND TRIAL TO COMPARE THE SAFETY AND IMMUNOGENECITY OF TETRABHAY DTwP-H COMBINATION VACCINE WITH SHANTETRA IN HEALTHY CHILDREN.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Sep 2016
Price :
$35
*
At a glance
- Drugs DTP-hepatitis B vaccine (Primary)
- Indications Diphtheria; Hepatitis B; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors Indian Immunologicals
- 02 Sep 2016 Planned End Date changed to 8 Nov 2010.
- 16 Sep 2010 New trial record